FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine – 4/23/2021

Join us for a joint virtual press conference with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss the Johnson & Johnson (Janssen) COVID-19 Vaccine.

Featuring:
• Janet Woodcock, M.D., Acting FDA Commissioner
• Rochelle Walensky, M.D., CDC Director
• Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
• Anne Schuchat, M.D., CDC Principal Deputy Director

#COVID19

source